AVI BioPharma Reports Favorable Safety and Pharmacokinetic Data ... (Hep C Treatment)

AVI BioPharma Reports Favorable Safety and Pharmacokinetic Data ...
Genetic Engineering News, NY - Jan 10, 2006(Nasdaq:AVII), today announced favorable safety and pharmacokinetic results from the first phase of its clinical trial for chronic active hepatitis C virus (HCV ...

Genelabs Updates Development Options for Its Investigational Lupus ...
PR Newswire (press release), NY - Jan 13, 2006... Prestara; potential de-listing from the Nasdaq Capital Market; fluctuations in Genelabs' stock price; failures or setbacks in our HCV research programs or in ...

Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2005 ...
PR Newswire (press release), NY - Jan 12, 2006... The Company also developed and manufactures the only FDA-approved blood screening assay for the simultaneous detection of HIV-1 and HCV, which is marketed by ...

Mortality falls in HIV/HCV coinfected Spaniards after the ...
Aidsmap, UK - Jan 12, 2006Mortality amongst Spanish injecting drug users coinfected with HIV and hepatitis C virus has fallen significantly since the introduction of effective HIV ...

A high note for commercial sales
Tyger Burger, South Africa - Jan 18, 2006... Sales in the heavy commercial vehicle (HCV) segment increased by an equally impressive 39,1 % on 2004 s sales, recording 5 177 unit sales during the year. ...

Confirmation of slots for PVF ref's congress ongoing
Sun.Star, Philippines - Jan 18, 2006... so that more potential players from the grassroots will be given the exposure to competition that they need in order to improve their game," Banzuela added.(HCV ...